Cerebral Embolic Protection Devices Market: Current Analysis and Forecast (2021-2027)
Emphasis on Product (Clarets Sentinel System, Keystone Hearts Triguard Device, And Embrella Embolic Deflector); End-Users (Hospitals, and Others); and Region & Country.
Cerebral Embolic Protection Devices Market was valued at ~US$ 650 million in 2020 and is expected to grow at a CAGR of ~8% over the forecast period (2021-2027). One of the most feared complications of transcatheter aortic valve implantation includes stroke or transient ischaemic attack. Cerebral Embolic protection devices reduce the risk of cerebrovascular accidents after TAVR. These devices aim to prevent procedural debris from reaching the cerebral vasculature. Cerebral embolic protection devices (CEPDs) were developed to reduce the risk of CVA and silent emboli. They are effective in filtering the debris and increasing the volume of ischemic embolic lesions, thus decreasing the risk of CVA. CEPDs are mesh filters preventing embolic material from entering the carotid arteries. There is a variety of CEPDs, differing in pore sizes, deployment location, and chemical composition. As per a study, the rate of successful deployment is achieved in over 90% of the cases, with success rates ranging from 64-100%. CEPDs can capture materials like thrombus, valve tissue, arterial valve tissue, foreign material, and calcification.
Key factors influencing the growth of cerebral embolic protection devices are the technological advancements in healthcare and additionally, due to the increasing aging population, the number of people needing TAVR procedures is increasing. The American population in the 65 and older age group is projected to be doubled from 2018 to 2060. The population is projected to expand from 52 million individuals in 2018 to 95 million people in 2060 which means the total population share will move from 16% to 23%. All these factors are influencing the increase of the cerebral embolic protection devices market in the forecasted period.
United States Mortality Rates Due to Aortic Stenosis Over the Years (%), 2008-2018
Boston Scientific, Keystone Heart, and Edward Lifesciences are some of the prominent players operating in the Cerebral Embolic Protection Devices Market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst Product, Keystone Heart’s Triguard Device segment holds the major share”
Based on the product the cerebral embolic protection devices is fragmented into Clarets Sentinel System, Keystones Heart’s Triguard Device, and Embrella Embolic Deflector. The heart’s trigaurd device segment of the cerebral embolic protection devices market was valued at US$ XX million in 2020 and is likely to reach US$ XX million by 2027 growing at a CAGR of XX% from 2021-2027. The Triguar is the only CE mark approved system. It can cover and protect all three major cerebral aortic vessels. The sentinel cerebral protection system has two filters within a 6F delivery catheter. Despite the increased fluoroscopic time, the deployment usually takes less than 10 min in 91% of cases. Sentinel can protect 74% of the brain volume, whereas embralla and triguard can protect 74% and 100% respectively. The cerebral protection market is estimated to grow with an increase in the number of valvular disfunction cases globally and also with more devices gaining FDA approval.
“Amongst End-User, Hospitals segment holds the major share”
Based on end-user the market is segmented into hospitals and others. The hospital segment generated revenue of US$ XX million in 2020 and is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of US$ XX million by 2027F. Cerebral embolic protection devices are used during the TAVR procedures which are performed in patients with aortic valve stenosis and cannot undergo open-heart surgery. Cerebral embolic protection devices can reduce the chances of strokes by collecting up to 90-95% of the debris.
“North America represents one of the largest markets of Cerebral Embolic Protection Devices Market”
For a better understanding of the market dynamics of the Cerebral Embolic Protection Devices market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Italy, United Kingdom, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC) and Rest of the World. North America dominated the market and grabbed around XX% market share owing to an increase in the geriatric population and the prevalence of aortic stenosis.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts
- The report presents a quick review of overall industry performance at one glance
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
- The study comprehensively covers the market across different segments
- Deep dive regional level analysis of the industry
Customization Options:
Cerebral Embolic Protection Devices market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Analyzing the historical market, estimation of the current market, and forecasting the future market of the Cerebral Embolic Protection Devices market were the three major steps undertaken to create and analyze the adoption of Cerebral Embolic Protection Devices in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the Cerebral Embolic Protection Devices market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the Cerebral Embolic Protection Devices through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Cerebral Embolic Protection Devices market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report as product, and end-user. Further country-level analyses were conducted to evaluate the overall adoption of Cerebral Embolic Protection Devices in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Cerebral Embolic Protection Devices. Further, we conducted factor analysis using dependent and independent variables such as the rise in the geriatric population and awareness among people. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, merger and acquisition, business expansion, and product launches in the Cerebral Embolic Protection Devices sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Cerebral Embolic Protection Devices market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e. bottom-up/top-down approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of value (US$) and the adoption rate of Cerebral Embolic Protection Devices across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the Cerebral Embolic Protection Devices market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Cerebral Embolic Protection Devices market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of type and their type of the Cerebral Embolic Protection Devices market.
The main objective of the Cerebral Embolic Protection Devices Market Study
The current & future market trends of Cerebral Embolic Protection Devices were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of Cerebral Embolic Protection Devices in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of type and their subtypes
- Define and analysis of the regulatory framework for the Cerebral Embolic Protection Devices industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the Cerebral Embolic Protection Devices market for the major region
- Major regions studied in the report include North America (the U.S, Canada, and Rest of North America), Europe (Germany, United Kingdom, France, Spain, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of Asia-Pacific), and the Rest of the World
- Company profiles of the Cerebral Embolic Protection Devices market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
